Voyager Therapeutics (VYGR) Current Leases (2019 - 2025)
Historic Current Leases for Voyager Therapeutics (VYGR) over the last 7 years, with Q3 2025 value amounting to $7.8 million.
- Voyager Therapeutics' Current Leases rose 1245.16% to $7.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.8 million, marking a year-over-year increase of 1245.16%. This contributed to the annual value of $7.2 million for FY2024, which is 12584.37% up from last year.
- Per Voyager Therapeutics' latest filing, its Current Leases stood at $7.8 million for Q3 2025, which was up 1245.16% from $7.6 million recorded in Q2 2025.
- In the past 5 years, Voyager Therapeutics' Current Leases registered a high of $7.8 million during Q3 2025, and its lowest value of $2.5 million during Q2 2022.
- Over the past 5 years, Voyager Therapeutics' median Current Leases value was $5.2 million (recorded in 2021), while the average stood at $5.1 million.
- Its Current Leases has fluctuated over the past 5 years, first plummeted by 4916.53% in 2022, then surged by 12584.37% in 2024.
- Voyager Therapeutics' Current Leases (Quarter) stood at $5.6 million in 2021, then tumbled by 49.17% to $2.8 million in 2022, then grew by 12.99% to $3.2 million in 2023, then surged by 125.84% to $7.2 million in 2024, then increased by 8.59% to $7.8 million in 2025.
- Its last three reported values are $7.8 million in Q3 2025, $7.6 million for Q2 2025, and $7.4 million during Q1 2025.